Alpha Cognition Inc. Common Stock (ACOG) Deep Dive Video
Summary
Alpha Cognition offers a high-risk, high-upside Alzheimer’s commercialization story, with Zunveyl’s superior tolerability, 93% gross margins, and long patent runway creating asymmetric potential if U.S. long-term care adoption accelerates.